Company / Shares Outstanding
TG Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
155.8M
FY2025
5-year range
140.6M / 155.8M
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#61 of 212
Health Care
What the data says
At 155836256.00, TG Therapeutics, Inc.'s shares outstanding ranks #152 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 49041354.00 in FY2016 to 155836256.00 in FY2025.
Based on SEC 10-K filings.
155836256.00 in FY2025 with a 5-year CAGR of +7.3%.
Increased from 146385388.00 to 155836256.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
#152 of 212 in Health CareTop 71% of 212This company 155.8M Sector average 306.7M
▼
-49.2% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 2.9% year-over-year.
- Ranks #61 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 155.8M | +2.9% |
| FY2024 | 151.4M | +3.4% |
| FY2023 | 146.4M | +2.2% |
| FY2022 | 143.3M | +1.9% |
| FY2021 | 140.6M | +28.5% |
| FY2020 | 109.4M | +30.4% |
| FY2019 | 83.9M | +14.7% |
| FY2018 | 73.1M | +17.8% |
| FY2017 | 62.1M | +26.6% |
| FY2016 | 49.0M | +7.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026